Prime

Type your tag names separated by a space and hit enter

Evaluation of a naloxone distribution and administration program in New York City.

Abstract

Naloxone, an opiate antagonist that can avert opiate overdose mortality, has only recently been prescribed to drug users in a few jurisdictions (Chicago, Baltimore, New Mexico, New York City, and San Francisco) in the United States. This report summarizes the first systematic evaluation of large-scale naloxone distribution among injection drug users (IDUs) in the United States. In 2005, we conducted an evaluation of a comprehensive overdose prevention and naloxone administration training program in New York City. One hundred twenty-two IDUs at syringe exchange programs (SEPs) were trained in Skills and Knowledge on Overdose Prevention (SKOOP), and all were given a prescription for naloxone by a physician. Participants in SKOOP were over the age of 18, current participants of SEPs, and current or former drug users. Participants completed a questionnaire that assessed overdose experience and naloxone use. Naloxone was administered 82 times; 68 (83.0%) persons who had naloxone administered to them lived, and the outcome of 14 (17.1%) overdoses was unknown. Ninety-seven of 118 participants (82.2%) said they felt comfortable to very comfortable using naloxone if indicated; 94 of 109 (86.2%) said they would want naloxone administered if overdosing. Naloxone administration by IDUs is feasible as part of a comprehensive overdose prevention strategy and may be a practicable way to reduce overdose deaths on a larger scale.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY, USA.

    , , , , ,

    Source

    Substance use & misuse 43:7 2008 pg 858-70

    MeSH

    Attitude to Health
    Comprehensive Health Care
    Drug Overdose
    Drug Prescriptions
    Drug Utilization
    Heroin Dependence
    Humans
    Injections, Intramuscular
    Naloxone
    Narcotic Antagonists
    Needle-Exchange Programs
    New York City
    Patient Education as Topic
    Preventive Health Services
    Program Evaluation
    Substance Abuse, Intravenous

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't
    Research Support, U.S. Gov't, P.H.S.

    Language

    eng

    PubMed ID

    18570021

    Citation

    TY - JOUR T1 - Evaluation of a naloxone distribution and administration program in New York City. AU - Piper,Tinka Markham, AU - Stancliff,Sharon, AU - Rudenstine,Sasha, AU - Sherman,Susan, AU - Nandi,Vijay, AU - Clear,Allan, AU - Galea,Sandro, PY - 2008/6/24/pubmed PY - 2008/8/23/medline PY - 2008/6/24/entrez SP - 858 EP - 70 JF - Substance use & misuse JO - Subst Use Misuse VL - 43 IS - 7 N2 - Naloxone, an opiate antagonist that can avert opiate overdose mortality, has only recently been prescribed to drug users in a few jurisdictions (Chicago, Baltimore, New Mexico, New York City, and San Francisco) in the United States. This report summarizes the first systematic evaluation of large-scale naloxone distribution among injection drug users (IDUs) in the United States. In 2005, we conducted an evaluation of a comprehensive overdose prevention and naloxone administration training program in New York City. One hundred twenty-two IDUs at syringe exchange programs (SEPs) were trained in Skills and Knowledge on Overdose Prevention (SKOOP), and all were given a prescription for naloxone by a physician. Participants in SKOOP were over the age of 18, current participants of SEPs, and current or former drug users. Participants completed a questionnaire that assessed overdose experience and naloxone use. Naloxone was administered 82 times; 68 (83.0%) persons who had naloxone administered to them lived, and the outcome of 14 (17.1%) overdoses was unknown. Ninety-seven of 118 participants (82.2%) said they felt comfortable to very comfortable using naloxone if indicated; 94 of 109 (86.2%) said they would want naloxone administered if overdosing. Naloxone administration by IDUs is feasible as part of a comprehensive overdose prevention strategy and may be a practicable way to reduce overdose deaths on a larger scale. SN - 1082-6084 UR - https://www.unboundmedicine.com/medline/citation/18570021/Evaluation_of_a_naloxone_distribution_and_administration_program_in_New_York_City_ L2 - http://informahealthcare.com/doi/abs/10.1080/10826080701801261 ER -